After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...

Illumina, Inc. offers sequencing- and array-based solutions ... specific genes, and RNA or other genomic regions of interest.

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 ...

With an installed base of more than 25,000 sequencing systems, Illumina holds around 80% of ... Avidity Biosciences (RNA 4.32%) develops targeted RNA therapeutics. It specializes in antibody ...

Chicago Partners Investment Group LLC acquired a new stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) in the 4th quarter, according to the company in its most recent filing with the ...

based Illumina ... innovative sequencing- and array-based solutions for genotyping, copy number variation analysis, methylation studies, and gene expression profiling of DNA and RNA.

Illumina is the world's largest provider ... system offers the potential to undertake multiomics by enabling RNA and protein sequencing on Illumina platforms which is not possible with ctDNA.